# Galmed Pharmaceuticals Ltd. (GLMD)

> Healthcare · IL · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/GLMD/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -1.91M | $ -2.54M | $ 0 | $ 13.95M |
| 2025 | $ 0 | $ -10.56M | $ -6.47M | $ 0 | $ 15.78M |
| 2024 | $ 0 | $ -7.90M | $ -6.18M | $ 0 | $ 16.33M |
| 2023 | $ 0 | $ -7.47M | $ -6.64M | $ 41.0K | $ 13.88M |
| 2022 | $ 0 | $ -19.96M | $ -20.67M | $ 215.0K | $ 13.42M |
| 2021 | $ 0 | $ -38.59M | $ -39.11M | $ 229.0K | $ 30.50M |
| 2020 | $ 0 | $ -36.65M | $ -33.54M | $ 216.0K | $ 44.15M |
| 2019 | $ 0 | $ -26.41M | $ -19.30M | $ 352.0K | $ 69.85M |
| 2018 | $ 2.69M | $ -13.02M | $ -12.04M | $ 0 | $ 87.89M |
| 2017 | $ 1.46M | $ -16.57M | $ -16.27M | $ 0 | $ 15.80M |
| 2016 | $ 642.5K | $ -23.32M | $ -16.71M | $ 0 | $ 11.08M |
| 2015 | $ 0 | $ -14.91M | $ -12.12M | $ 0 | $ 21.55M |
| 2014 | $ 0 | $ -12.86M | $ -14.15M | $ 0 | $ 31.41M |
| 2013 | $ 0 | $ -24.87M | $ -3.61M | $ 0 | $ -1.95M |
| 2012 | $ 0 | $ -1.8K | $ -1.5K | $ 0 | $ -2.0K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.15 |
| Current Ratio | 7.71 |

## Other views

- [Metrics](https://sponda.capital/en/GLMD.md)
- [Charts](https://sponda.capital/en/GLMD/charts.md)
- [Compare](https://sponda.capital/en/GLMD/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.